Name | Type | Posted | Actions |
|---|---|---|---|
SDCC_RFI_NIAID_26.pdf | Jun 11, 2026 |
Request for Information (RFI): Statistical and Data Coordinating Center (SDCC) for Clinical Research in Infectious Diseases (CRID)
Contact and place of performance
Miranda Adams
USA
THIS IS A REQUEST FOR INFORMATION (RFI) ONLY In accordance with RFO 15.101(c), this RFI is issued solely for information and planning purposes. It does not constitute a solicitation for proposals, quotations, or abstracts, nor does it obligate the Government to award a contract or pay for any information provided. Responses will not be returned. No reimbursement will be made for costs associated with responding to th...
View moreAs part of clinical research portfolio, NIAID has regulatory obligations for clinical trials that include standardized deliverables, reporting, safety oversight, and monitoring. NIAID therefore requires resources to support its clinical research activities in compliance with regulatory requirements. One of those resources is a Statistical and Data Coordinating Center (SDCC) which provides centralized data management, statistical, and specimen tracking services essential to this clinical research portfolio. NIAID is exploring the re-competition of its Statistical and Data Coordinating Center (SDCC) for Clinical Research in Infectious Diseases (CRID) contract.
2. Purpose
The Government is issuing this RFI to:
Full RFI Attached.
The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is conducting market research to explore the re-competition of its contract for a Statistical and Data Coordinating Center (SDCC) for Clinical Research in Infectious Diseases (CRID). This center provides centralized data management, statistical analysis, and specimen tracking services essential to a clinical research portfolio that includes Phase 0-4 therapeutics and vaccine trials, surveillance studies, and diagnostic evaluations. The SDCC ensures these activities comply with regulatory obligations for standardized deliverables, reporting, safety oversight, and monitoring for both domestic and international clinical sites.
The primary purpose of this sources sought notice, identified under solicitation number NIH-NIAID-RFI-001-26, is to facilitate early engagement with industry, assess current market capabilities, and gather input on best practices to inform a future Statement of Work. This requirement falls under NAICS 541714 for Research and Development in Biotechnology (except Nanobiotechnology) and PSC R702 for Support- Management: Data Collection. There is no set-aside designated for this opportunity.
Responses to this Request for Information are due by July 8, 2026. The place of performance is located within the United States, and the primary point of contact for the agency is Miranda Adams. One attachment, titled SDCC_RFI_NIAID_26.pdf, was included with the notice published on June 11, 2026. This announcement is for planning purposes only and does not constitute a formal solicitation or a commitment to award a contract.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.